 |
|
|
| Oxaliplatin |
|
Oxaliplatin: perspectives and future developments
Michel Marty, Paul-Henry Cottu, Florence Lerebours, Naima Bedairia, Hamid Hocini, Marc Espié
|
 Résumé
Article gratuit
|
Oxaliplatin: a first DACH-platinum in oncology
Abderrhamane Laadem, Esteban Cvitkovic
|
Résumé
Article gratuit
 Summary
|
Pharmacokinetic properties of platinium derivatives
Michèle Boisdron-Celle, Anne Lebouil, Pierre Allain, Erick Gamelin
|
Résumé
Article gratuit
Summary
|
Oxaliplatin in combination with 5-fluoro-uracil and folinic acid as treatment of metastatic colorectal cancer
Thierry André, Christophe Louvet, Frédérique Maindrault-Goebel, Aimery de Gramont
|
Résumé
Article gratuit
Summary
|
Preclinical studies of oxaliplatin in combination chemotherapy
Eric Raymond, Sandrine Faivre, Anne-Marie Coudray, Christophe Louvet, Christian Gespach
|
Résumé
Article gratuit
Summary
|
Oxaliplatin in combination with non fluoropyrimidine drugs in colorectal cancer
Michel Ducreux, Karim Fizazi, Jean-François Seitz, Yves Becouarn, Jean-Pierre Armand
|
Résumé
Article gratuit
Summary
|
Clinical use of oxaliplatin in solid tumors
François Goldwasser, Jean-Louis Misset
|
Résumé
Article gratuit
Summary
|
Oxaliplatin: safety profile in metastatic colorectal cancer
Roland Bugat
|
Résumé
Article gratuit
Summary
|
|
